Generic drug sales continue to flourish in France, assisted by a favourable regulatory regime and a surge of patent expiries for leading drugs

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.474, 2005-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug patent expiry reduces costs by prompting a switch to generic drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

A Review of: “Generic Drug Product Development – Solid Oral Dosage Forms, Drugs and the Pharmaceutical Sciences # 143”

By Brittain Harry  

Pharmaceutical Development and Technology, Vol. 11, Iss. 3, 2006-09 ,pp. : 399-399

Informa Healthcare

Access to resources Recommend Favorite

Drug sales to soar in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Drug-eluting stents appear favourable for diabetic patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 587, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

US drug prices continue to rise, but savings on horizon

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 321, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite